Today, with the development of modern medicine, most diseases are treatable. The important thing is to detect them in time. Joined together, technology and modern have mixed their capacities so that today it’s much easier to respond quickly in order to save our health. The early diagnostics sometimes can be of great importance when especially when we are dealing with cancer-related diseases.
Today, modern diagnostic methods are more available, and so they are more accessible to those in need. Technological and medical and innovation are truly a major step in diagnosing and treating various diseases.
Although we are living in the information era, we’re still pretty uninformed about women pelvic floor diseases. That’s why we could say that education joined with modern diagnostic is of major importance in order to effectively prevent and treat this highly spread disease.
The Mission Of Renovia Inc
Renovia Inc. is the company headed by Marc Beer the CEO. This company has focused on making new products which are directed to solving problems connected to women pelvic floor.
This medical-tech company is situated in Boston where they are working on the development of diagnostic performing. These innovations are used for therapy purpose in urinary incontinence and pelvic floor disorders. Most researchers agree with the fact that this disorder is widely spread in women. To be more concrete, it affects more than 250 million women worldwide.
Investors Of Renovia Inc.
The first presented medical product of Renovia Inc. was the Leva, – approved officially by the FDA in 2018. Afterward, Renovia has attracted plenty of investors, among them The Longwood Fund. The Longwood Fund is an investment company that’s highly pointing to health care issues. They invested in Renovia, joining two other investment enterprises – Ascension Ventures from Missouri and Perceptive Advisors from New York. The funds will be invested in developing and testing of four different diagnostic devices. That’s also including the Leva devices of the new generation.
Marc Beer CEO of Renovia Inc. is extremely satisfied with the support that the company has received from some of the leading investors. Marc Beer claims that this is the product of good cooperation. As he said, Renovia and company’s investors are sharing the exact same vision of future healthcare and prevention matters. Together, they hope they will manage to improve the treatment and the life quality for thousands of women who are suffering from pelvic floor disorder.
Innovations Of Renovia Inc.
Marc Beer recently revealed facts about combining the digital health platform and innovative sensor technology. This combination in diagnostics will give some very valuable information regarding the medical procedure, new treatment possibilities, and a general understanding and education on the subject of the pelvic floor disorder. However, Renovia Inc. hasn’t made its official statement considering investments and the new lines of their products.
Marc Beer’s business engagement with Renovia Inc. dates from 2015.
Before he becomes the CEO of Renovia Inc. he was working in other medical companies. Marc Beer brought to Renovia more than 25 years of his wide experience in biotechnological developing, as well as in pharmacy. Marc Beer was one who closed a chain of financing with some of the leading capital funds. Learn more: https://www.bizjournals.com/boston/news/2018/08/21/ex-aegerion-chief-beer-raises-42m-for-womens.html